Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman (before or after menopause) who has been diagnosed with invasive breast cancer at stage II or III, and your cancer is either HER2-positive or triple-negative
- You have had surgery to remove the breast cancer, or you received treatment before surgery and still had some cancer remaining when surgery was performed (including a specific type called cT4d)
- Scans done around the time of your surgery (within about 1 month) showed no signs that the cancer has spread to other parts of your body
- You have no major other health conditions that would affect your participation
- You are in excellent general health and able to carry out normal daily activities without any limitations (a measure called ECOG performance status 0)
- You live close enough to the trial site to attend follow-up appointments
- You are able to understand the study and are willing to sign a consent form agreeing to take part
Who may not be able to join:
- You have a reason why you absolutely cannot have an MRI scan (for example, certain metal implants)
- You have a condition that makes having an MRI scan uncertain or potentially unsafe, unless there is a strong medical reason to proceed (confirm with trial site)
- You are older than 75 years of age
- You have had, or currently have, another type of cancer — unless it was a common skin cancer or an early-stage cervical cancer that was fully treated
- You have an uncontrolled serious illness, such as heart failure, unstable chest pain (angina), or a mental health or personal situation that would make it difficult to follow the study requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Monica Iorfida, MD, European Institute of Oncology
Phone: +390257489970
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
5-year overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.